Literature DB >> 23864650

Cyclin D1 determines estrogen signaling in the mammary gland in vivo.

Mathew C Casimiro1, Chenguang Wang, Zhiping Li, Gabriele Di Sante, Nicole E Willmart, Sankar Addya, Lei Chen, Yang Liu, Michael P Lisanti, Richard G Pestell.   

Abstract

The CCND1 gene, which is frequently overexpressed in cancers, encodes the regulatory subunit of a holoenzyme that phosphorylates the retinoblastoma protein. Although it is known that cyclin D1 regulates estrogen receptor (ER)α transactivation using heterologous reporter systems, the in vivo biological significance of cyclin D1 to estrogen-dependent signaling, and the molecular mechanisms by which cyclin D1 is involved, are yet to be elucidated. Herein, genome-wide expression profiling conducted of 17β-estradiol-treated castrated virgin mice deleted of the Ccnd1 gene demonstrated that cyclin D1 determines estrogen-dependent gene expression for 88% of estrogen-responsive genes in vivo. In addition, expression profiling of 17β-estradiol-stimulated cyclin D1 small interfering RNA treated MCF7 cells shows cyclin D1 is required for estrogen-mediated gene expression in vitro. Genome-wide chromatin immunoprecipitation-Seq analysis revealed a cyclin D1-DNA bound form associated with genes that were regulated by estrogen in a cyclin D1-dependent manner. The cyclin D1-dependent estrogen signaling pathways identified in vivo were highly enriched for extracellular membrane-associated growth factor receptors (epidermal growth factor receptor, ErbB3, and EphB3) and their ligands (amphiregulin, encoded by AREG gene), and matrix metalloproteinase. The AREG protein, a pivotal ligand for epidermal growth factor receptors to promote cellular proliferation, was induced by cyclin D1 via the AREG promoter. Chromatin immunoprecipitation analysis demonstrated the recruitment of cyclin D1 to the breast cancer 1 (Brca1)/ERα binding site of the Areg gene. Cyclin D1 genetic deletion demonstrated the in vivo requirement for cyclin D1 in assembling the estrogen-dependent amplified in breast cancer 1-associated multiprotein complex. The current studies define a requirement for cyclin D1 in estrogen-dependent signaling modules governing growth factor receptor and ligand expression in vivo and reveal a noncanonical function of cyclin D1 at ERα target gene promoters. Cyclin D1 mediates the convergence of ERα and growth factor signaling at a common cis-element of growth factor genes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23864650      PMCID: PMC3753428          DOI: 10.1210/me.2013-1065

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  61 in total

1.  Antisense expression for amphiregulin suppresses tumorigenicity of a transformed human breast epithelial cell line.

Authors:  L Ma; C Gauvillé; Y Berthois; G Millot; G R Johnson; F Calvo
Journal:  Oncogene       Date:  1999-11-11       Impact factor: 9.867

2.  Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway.

Authors:  R J Lee; C Albanese; M Fu; M D'Amico; B Lin; G Watanabe; G K Haines; P M Siegel; M C Hung; Y Yarden; J M Horowitz; W J Muller; R G Pestell
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

3.  Cyclin D1 induction of cellular migration requires p27(KIP1).

Authors:  Zhiping Li; Xuanmao Jiao; Chenguang Wang; Xiaoming Ju; Yinan Lu; Liangping Yuan; Michael P Lisanti; Sanjay Katiyar; Richard G Pestell
Journal:  Cancer Res       Date:  2006-10-15       Impact factor: 12.701

4.  Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression.

Authors:  Meng-Min Liu; Chris Albanese; Carol M Anderson; Kristin Hilty; Paul Webb; Rosalie M Uht; Richard H Price; Richard G Pestell; Peter J Kushner
Journal:  J Biol Chem       Date:  2002-05-01       Impact factor: 5.157

5.  Proximal events in signaling by plasma membrane estrogen receptors.

Authors:  Mahnaz Razandi; Ali Pedram; Steven T Park; Ellis R Levin
Journal:  J Biol Chem       Date:  2002-11-05       Impact factor: 5.157

6.  Activation of the cyclin D1 gene by the E1A-associated protein p300 through AP-1 inhibits cellular apoptosis.

Authors:  C Albanese; M D'Amico; A T Reutens; M Fu; G Watanabe; R J Lee; R N Kitsis; B Henglein; M Avantaggiati; K Somasundaram; B Thimmapaya; R G Pestell
Journal:  J Biol Chem       Date:  1999-11-26       Impact factor: 5.157

7.  p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling.

Authors:  James Hulit; Richard J Lee; Zhiping Li; Chenguang Wang; Sanjay Katiyar; Jianguo Yang; Andrew A Quong; Kongming Wu; Chris Albanese; Robert Russell; Dolores Di Vizio; Andrew Koff; Saiinder Thummala; Hui Zhang; Jennifer Harrell; Hong Sun; William J Muller; Giorgio Inghirami; Michael P Lisanti; Richard G Pestell
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

8.  Alternative cyclin D1 splice forms differentially regulate the DNA damage response.

Authors:  Zhiping Li; Xuanmao Jiao; Chenguang Wang; L Andrew Shirley; Hany Elsaleh; Olav Dahl; Min Wang; Evi Soutoglou; Erik S Knudsen; Richard G Pestell
Journal:  Cancer Res       Date:  2010-10-12       Impact factor: 12.701

9.  Fibroblast growth factor-2 induces Lef/Tcf-dependent transcription in human endothelial cells.

Authors:  Wolfgang Holnthoner; Manuela Pillinger; Marion Groger; Klaus Wolff; Anthony W Ashton; Chris Albanese; Peter Neumeister; Richard G Pestell; Peter Petzelbauer
Journal:  J Biol Chem       Date:  2002-09-15       Impact factor: 5.157

10.  Cyclin D1 governs adhesion and motility of macrophages.

Authors:  Peter Neumeister; Fiona J Pixley; Ying Xiong; Huafeng Xie; Kongming Wu; Anthony Ashton; Michael Cammer; Amanda Chan; Marc Symons; E Richard Stanley; Richard G Pestell
Journal:  Mol Biol Cell       Date:  2003-02-21       Impact factor: 4.138

View more
  26 in total

Review 1.  The Role of CDK4/6 Inhibition in Breast Cancer.

Authors:  Conleth G Murphy; Maura N Dickler
Journal:  Oncologist       Date:  2015-04-15

2.  v-Src Oncogene Induces Trop2 Proteolytic Activation via Cyclin D1.

Authors:  Xiaoming Ju; Xuanmao Jiao; Adam Ertel; Mathew C Casimiro; Gabriele Di Sante; Shengqiong Deng; Zhiping Li; Agnese Di Rocco; Tingting Zhan; Adam Hawkins; Tanya Stoyanova; Sebastiano Andò; Alessandro Fatatis; Michael P Lisanti; Leonard G Gomella; Lucia R Languino; Richard G Pestell
Journal:  Cancer Res       Date:  2016-09-15       Impact factor: 12.701

Review 3.  Genetically engineered ERα-positive breast cancer mouse models.

Authors:  Sarah A Dabydeen; Priscilla A Furth
Journal:  Endocr Relat Cancer       Date:  2014-05-06       Impact factor: 5.678

Review 4.  Minireview: Tipping the balance: ligand-independent activation of steroid receptors.

Authors:  Marcela A Bennesch; Didier Picard
Journal:  Mol Endocrinol       Date:  2015-01-27

5.  The number of titrated microRNA species dictates ceRNA regulation.

Authors:  Hua-Sheng Chiu; María Rodríguez Martínez; Elena V Komissarova; David Llobet-Navas; Mukesh Bansal; Evan O Paull; José Silva; Xuerui Yang; Pavel Sumazin; Andrea Califano
Journal:  Nucleic Acids Res       Date:  2018-05-18       Impact factor: 16.971

6.  Let-7c blocks estrogen-activated Wnt signaling in induction of self-renewal of breast cancer stem cells.

Authors:  X Sun; C Xu; S-C Tang; J Wang; H Wang; P Wang; N Du; S Qin; G Li; S Xu; Z Tao; Dapeng Liu; H Ren
Journal:  Cancer Gene Ther       Date:  2016-03-18       Impact factor: 5.987

7.  Sex-dependent effects of estrogen pellets in human liver cancer xenograft models.

Authors:  Sungryong Oh; Kiheon Choi; Kyoung Mee Kim; Joohee Jung
Journal:  Toxicol Res       Date:  2019-12-02

8.  Placental estrogen suppresses cyclin D1 expression in the nonhuman primate fetal adrenal cortex.

Authors:  Adina Dumitrescu; Graham W Aberdeen; Gerald J Pepe; Eugene D Albrecht
Journal:  Endocrinology       Date:  2014-09-23       Impact factor: 4.736

9.  Cyclin D1 integrates estrogen-mediated DNA damage repair signaling.

Authors:  Zhiping Li; Ke Chen; Xuanmao Jiao; Chenguang Wang; Nicole E Willmarth; Mathew C Casimiro; Weihua Li; Xiaoming Ju; Sung Hoon Kim; Michael P Lisanti; John A Katzenellenbogen; Richard G Pestell
Journal:  Cancer Res       Date:  2014-05-15       Impact factor: 12.701

10.  Cyclin D1 Promotes Androgen-Dependent DNA Damage Repair in Prostate Cancer Cells.

Authors:  Mathew C Casimiro; Gabriele Di Sante; Xiaoming Ju; Zhiping Li; Ke Chen; Marco Crosariol; Ismail Yaman; Michael Gormley; Hui Meng; Michael P Lisanti; Richard G Pestell
Journal:  Cancer Res       Date:  2015-11-18       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.